SCHEMBL19814930

SCHEMBL19814930

OB(O)c1cnc(Cl)cc1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.40
▸ MAP4K4 O95819 1/20 0.37
▸ BACE1 P56817 1/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ CYP2A6 P11509 1/20 0.35
▸ MGLL Q99685 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ USP7 Q93009 1/20 0.34
▸ METAP2 P50579 1/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ PDGFRA P16234 1/20 0.34
▸ CSNK1A1 P48729 1/20 0.34
▸ CDK7 P50613 1/20 0.34
▸ BTK Q06187 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14379732 0.77 LMNA (0.42) JAK2MAP4K4RAB9ANPC1CYP2A6
SCHEMBL23277179 0.76 CYP2A6 (0.46) JAK2MAP4K4BACE1RAB9ANPC1
SCHEMBL30919693 0.76 CYP2A6 (0.46) JAK2MAP4K4BACE1RAB9ANPC1
SCHEMBL28413950 0.74 BACE1 (0.52) JAK2MAP4K4BACE1RAB9ANPC1
SCHEMBL16702402 0.73 MAP4K4 (0.47) JAK2MAP4K4RAB9ANPC1CYP2A6
SCHEMBL21290181 0.73 MAP4K4 (0.47) JAK2MAP4K4RAB9ANPC1CYP2A6
SCHEMBL21223238 0.73 MAP4K4 (0.40) JAK2MAP4K4BACE1RAB9ANPC1
SCHEMBL24589281 0.73 ESR2 (0.44) JAK2MAP4K4RAB9ANPC1CYP2A6
SCHEMBL19815810 0.73 ALDH1A1 (0.43) JAK2MAP4K4BACE1RAB9ANPC1
SCHEMBL20164147 0.73 PTGDR2 (0.45) BACE1CYP2A6LMNAKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12466805-B2 Pharmaceutical compounds ALMAC DISCOVERY LIMITED (GB) 2025-11-11 — — US disclosed
CN-109790146-B Pharmaceutical compounds 阿尔麦克探索有限公司 2022-08-23 — — CN disclosed
EP-3490982-B1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LTD (GB) 2022-04-20 — — EP disclosed
US-20220002264-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2022-01-06 — — US disclosed
US-11053213-B2 Pharmaceutical compounds ALMAC DISCOVERY LIMITED (GB) 2021-07-06 — — US disclosed
US-20190233394-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2019-08-01 — — US disclosed
EP-3490982-A1 PHARMACEUTICAL COMPOUNDS Almac Discovery Limited (GB) 2019-06-05 — — EP disclosed
WO-2018020242-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2018-02-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12466805-B2 Pharmaceutical compounds USP19, USP18, UBE2I JAK2 2336/4885MAP4K4 3625/4885BACE1 354/4885
US-20190233394-A1 PHARMACEUTICAL COMPOUNDS USP19, USP18, UBE2I JAK2 2336/4885MAP4K4 3625/4885BACE1 354/4885
US-20220002264-A1 PHARMACEUTICAL COMPOUNDS USP19, USP18, UBE2I JAK2 2336/4885MAP4K4 3625/4885BACE1 354/4885
US-11053213-B2 Pharmaceutical compounds USP19, USP18, UBE2I JAK2 2336/4885MAP4K4 3625/4885BACE1 354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback